Recent Coverage

 

March 23, 2016

The Asahi Shimbun
Shiseido to trial baldness ‘cure’ for planned commercial launch in 2018
Find full article here online, at The Asahi Shimbun. By: TOMOYUKI IZAWA/ Staff Writer Major cosmetics maker Shiseido Co. plans to grow into the baldness... Read full article

March 3, 2016

The Life Sciences Report: Streetwise Reports
Embrace Low-Cap Biotech for High Gains: Eden Rahim of Next Edge Capital
Source: George S. Mack of The Life Sciences Report  (3/2/16) View the full article as is appears here, on The Life Sciences Report. Eden Rahim... Read full article

November 16, 2015

The Globe and Mail
How Japan ‘Changed the System’
Japan’s Bold Steps By: Iain Marlow ASUKE, JAPAN The Globe and Mail Last updated: Saturday, Nov. 14, 2015 3:41PM EST People over the age... Read full article

October 27, 2015

Financial Post
Canada’s emerging cell therapy biotech industry
Canadian companies driving global breakthroughs in regenerative medicine By Kathryn Boothby To read this article on the Financial Post website, click here. Rapid advances in... Read full article

September 16, 2015

BioInsights
Japan’s regulatory gamble and what it means for the Industry
Navigating the Global Regulatory Landscape Written by: Lee Buckler & Colin Lee Novick The Follower Takes the Lead:  How Japan’s trifecta of economic policy,... Read full article

September 9, 2015

The Life Sciences Report
Alan Leong of BioWatch Looks Beyond the Buzz for Solid Early-Stage Plays RP, CAPR, CTRV, CPXX, SRNE, SNSS
To read the full article as it appears on The Life Sciences Report, click here. Source: Gail Dutton of The Life Sciences Report  (9/9/15) CAR... Read full article

August 12, 2015

The Life Science Report
Harness Biotech Volatility with an Options Strategy: Theta Strategy Capital’s Eden Rahim
To read the full article as it appears on The Life Science Report, please click here. Volatility is the nature of the biotech beast,... Read full article

August 5, 2015

The Life Science Report
Regenerative Medicine in Japan: CJ Partners’ Colin Lee Novick
Source: Gail Dutton of The Life Sciences Report Regenerative medicine is just beginning to be understood by governments and investors alike. Last autumn, new... Read full article

July 16, 2015

Cantech Letter
5 Questions with David Hall
Click here to view the article on Cantech Letter Vancouver-based RepliCel Life Sciences (TSXV:RP) concentrated on hair regeneration until 2011, participating in the $3... Read full article

May 29, 2015

Fisher BioServices Blog
Japan’s Gambit for Cell Therapy Clinical Trials
Please click here to visit Fisher BioServices Blog. Posted by Richard Tsai on May 28, 2015 11:00:00 AM When Shinzo Abe was re-elected as Japan’s... Read full article